Tengion is developing product candidates that hold the potential to transform the treatment of organ and tissue impairment, failure and loss.
Tengion Neo-Urinary Conduit™
Watch as the neo-urinary conduit development process is described for use in patients with bladder cancer. The Tengion Neo-Urinary Conduit™ is currently being evaluated in human clinical trials and is not commercially available.
*Internet Explorer users only: you may be redirected to upgrade security components and install an Active X control.